Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - betahistine dihydrochloride 16 mg - tablet - 16 mg - betahistine dihydrochloride 16 mg - betahistine

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - betahistine dihydrochloride -

Malta - English - Medicines Authority

azure pharmaceuticals ltd 12 hamilton drive, the rock road, blackrock, co. louth a91 t997, ireland - tablet - betahistine dihydrochloride 16 mg - other nervous system drugs

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - betahistine dihydrochloride, quantity: 16 mg - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; crospovidone; stearic acid; povidone; lactose monohydrate; microcrystalline cellulose - meniere's syndrome as defined by the following core symptoms: vertigo (with nausea/vomiting); hearing loss (hardness of hearing); tinnitus.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - betahistine dihydrochloride, quantity: 16 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; citric acid; colloidal anhydrous silica; mannitol; purified talc - meniere's syndrome as defined by the following core symptoms: vertigo (with nausea/vomiting), hearing loss (hardness of hearing) and tinnitus.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - betahistine dihydrochloride - oral tablet - 16mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

arrow generics ltd - betahistine dihydrochloride - oral tablet - 16mg

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare limited - betahistine dihydrochloride - tablets - 16 milligram - betahistine

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - betahistine dihydrochloride, quantity: 16 mg - tablet - excipient ingredients: lactose monohydrate; maize starch; microcrystalline cellulose; citric acid; povidone; crospovidone; hydrogenated vegetable oil - meniere's syndrome as defined by the following core symptoms: vertigo (with nausea / vomiting), hearing loss (hardness of hearing), tinnitus.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - betahistine dihydrochloride -